Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Kathryn Phillips, PhD

    SchoolUCSF School of Pharmacy
    DepartmentClinical Pharmacy
    Address3333 Calif. St,Laurel Heights
    San Francisco CA 94118
    vCardDownload vCard

      Collapse Biography 
      Collapse Awards and Honors
      Harvard/Dept of Navy (civilian)1985 - 1986Training Award for mid-career Master's Degree
      UC Berkeley1987 - 1988UC Berkeley Graduate Fellowship
      UC-Berkeley1989 - 1989Outstanding Graduate Student Instructor
      Am J Prev Med1999 - 1999Commendation for outstanding journal reviews
      Univ of CT2003 - 200350 Most Cited HIV Behavioral Researchers in Past Decade
      Research Triangle Institute2010 - 2010Most cited article award

      Collapse Overview 
      Collapse Overview
      Kathryn A. Phillips, PhD, a health services researcher and health economist and leader in the application of new technologies to improve healthcare, is the founding director of the Center for Translational and Policy Research on Personalized Medicine (TRANSPERS) in the School of Pharmacy at the University of California, San Francisco (UCSF). She is also a professor of health economics and health services research in the Department of Clinical Pharmacy at UCSF, with additional appointments in the UCSF Philip R. Lee Institute for Health Policy Studies and UCSF Helen Diller Family Comprehensive Cancer Center

      Kathryn focuses on the value of new technologies and how to most effectively and efficiently implement them into health care. Her core specialty is personalized (or precision) medicine — a new era of healthcare where medical interventions can be tailored to individual patients based on their unique genetic make-up. Her work spans multiple disciplines, including basic, clinical and social sciences, and brings together leading experts in academia, industry, healthcare, payers, and government. Kathryn led one of the earliest studies on the societal implications of pharmacogenomics, underscoring its potential to reduce the incidence of adverse drug reactions (JAMA, 2001). Her pioneering research on the application of health services research to personalized medicine has revealed insights on how to bridge the gap between emerging technologies and their use in the clinic. Kathryn has also conducted seminal work on HIV, as her analysis of HIV home testing informed the FDA’s decision to approve the first home collection HIV test (New England Journal of Medicine, 1995).

      Kathryn has published more than 100 peer-reviewed articles in major journals, including JAMA, the New England Journal of Medicine, and Health Affairs and has had continuous funding from the US. National Institutes of Health as a principal investigator for 25 years. She currently serves on the editorial boards of the journal Health Affairs (rated as the top policy journal) and several leading journals on personalized medicine. Kathryn has served on national and international scientific advisory committees and workshops including work for GenomeCanada, Institutes of Medicine, Food and Drug Administration, Centers for Disease Control and Prevention, and the President’s Council of Advisors on Science and Technology. She has also served as an advisor to various international and industry organizations, including more than 35 biotechnology companies and venture capital firms. Most recently, she has been asked by the Patient-Centered Outcomes Research Institute (PCORI) - the largest funder of comparative effectiveness research in the world - to develop potential topics for their research agenda on personalized/precision medicine.

      Collapse Interests
      Health services research, health economics, policy analysis, personalized/precision medicine, value of diagnostics, population screening, utilization and cost–effectiveness of care, coverage/reimbursement policies, cancer, creating a high value health care system, cost–effectiveness analysis, secondary dataset analysis, systematic literature review, comparative effectiveness research, quantitative preference measurement, women’s reproductive health

      Collapse ORNG Applications 
      Collapse Featured Publications
      Collapse Websites
      Collapse In The News
      Collapse NIH Awarded Grants
      Collapse Featured Videos

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Clain E, Trosman JR, Douglas MP, Weldon CB, Phillips KA. Availability and payer coverage of BRCA1/2 tests and gene panels. Nat Biotechnol. 2015 Sep 8; 33(9):900-2.
        View in: PubMed
      2. Phillips KA, Pletcher MJ, Ladabaum U. Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing. Technol Health Care. 2015 Jun 10; 23(3):373-9.
        View in: PubMed
      3. Phillips KA, Ladabaum U, Pletcher MJ, Marshall DA, Douglas MP. Key emerging themes for assessing the cost-effectiveness of reporting incidental findings. Genet Med. 2015 Apr; 17(4):314-5.
        View in: PubMed
      4. Trosman JR, Weldon CB, Kelley RK, Phillips KA. Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in. J Natl Compr Canc Netw. 2015 Mar; 13(3):311-8.
        View in: PubMed
      5. Foster DG, Biggs MA, Phillips KA, Grindlay K, Grossman D. Potential public sector cost-savings from over-the-counter access to oral contraceptives. Contraception. 2015 May; 91(5):373-9.
        View in: PubMed
      6. Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Genomic sequencing: assessing the health care system, policy, and big-data implications. Health Aff (Millwood). 2014 Jul; 33(7):1246-53.
        View in: PubMed PMC4113721
      7. Balakrishnan N, Pritchard J, Ericson M, Grindem C, Phillips K, Jennings S, Mathews K, Tran H, Birkenheuer AJ, Breitschwerdt EB. Prostatitis, steatitis, and diarrhea in a dog following presumptive flea-borne transmission of Bartonella henselae. J Clin Microbiol. 2014 Sep; 52(9):3447-52.
        View in: PubMed
      8. Pletcher MJ, Pignone M, Earnshaw S, McDade C, Phillips KA, Auer R, Zablotska L, Greenland P. Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2014 Mar; 7(2):276-84.
        View in: PubMed PMC4156513
      9. Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P. The economic value of personalized medicine tests: what we know and what we need to know. Genet Med. 2014 Mar; 16(3):251-7.
        View in: PubMed PMC3949119
      10. Liang SY, Grossman D, Phillips KA. User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives. Contraception. 2012 Dec; 86(6):666-72.
        View in: PubMed
      11. Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care. 2012 May; 18(5):e179-85.
        View in: PubMed
      12. Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract. 2012 May; 8(3 Suppl):e24s-30s.
        View in: PubMed PMC3348599
      13. Wang G, Beattie MS, Ponce NA, Phillips KA. Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genet Med. 2011 Dec; 13(12):1045-50.
        View in: PubMed
      14. Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med. 2011 Oct; 13(10):853-60.
        View in: PubMed PMC3774033
      15. Kiely BE, Friedlander ML, Milne RL, Stanhope L, Russell P, Jenkins MA, Weideman P, McLachlan SA, Grant P. Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer. Fam Cancer. 2011 Sep; 10(3):505-14.
        View in: PubMed PMC3175342
      16. Harvey SL, Milne RL, McLachlan SA, Friedlander ML, Birch KE, Weideman P. Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families. Breast Cancer Res Treat. 2011 Dec; 130(3):1057-61.
        View in: PubMed
      17. Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011 Jul 19; 155(2):69-79.
        View in: PubMed PMC3793257
      18. Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat. 2011 Nov; 130(2):619-26.
        View in: PubMed PMC3590013
      19. Liang SY, Phillips KA, Wang G, Keohane C, Armstrong J, Morris WM, Haas JS. Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care. 2011 Jun; 49(6):e1-8.
        View in: PubMed PMC3383782
      20. Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract. 2011 May; 7(3 Suppl):18s-24s.
        View in: PubMed PMC3092460
      21. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract. 2011 May; 7(3 Suppl):e1s-7s.
        View in: PubMed PMC3092459
      22. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care. 2011 May; 17(5 Spec No):e174-81.
        View in: PubMed
      23. Trosman JR, Van Bebber SL, Phillips KA. Health technology assessment and private payers's coverage of personalized medicine. Am J Manag Care. 2011 May; 17 Suppl 5 Developing:SP53-60.
        View in: PubMed
      24. Johnson FR, Mohamed AF, Ozdemir S, Marshall DA, Phillips KA. How does cost matter in health-care discrete-choice experiments? Health Econ. 2011 Mar; 20(3):323-30.
        View in: PubMed PMC3918954
      25. Kelley RK, Van Bebber SL, Phillips KA, Venook AP. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw. 2011 Jan; 9(1):13-25.
        View in: PubMed PMC3695822
      26. Liang SY, Grossman D, Phillips KA. Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006. Contraception. 2011 Jun; 83(6):528-36.
        View in: PubMed
      27. Trosman JR, Van Bebber SL, Phillips KA. Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay. J Oncol Pract. 2010 Sep; 6(5):238-42.
        View in: PubMed PMC2936466
      28. Phillips KA, Grossman D, Weitz TA, Trussell J. Bringing evidence to the debate on abortion coverage in health reform legislation: findings from a national survey in the United States. Contraception. 2010 Aug; 82(2):129-30.
        View in: PubMed
      29. Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van Bebber S, Phillips KA. How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ. 2009 Dec; 18(12):1420-39.
        View in: PubMed PMC3964796
      30. Liang SY, Haas JS, Phillips KA. Medicare formulary coverage for top-selling biologics. Nat Biotechnol. 2009 Dec; 27(12):1082-4.
        View in: PubMed PMC2845541
      31. Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL. Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer. 2009 Nov 15; 115(22):5166-74.
        View in: PubMed PMC2783254
      32. Johnson FR, Ozdemir S, Phillips KA. Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med. 2010 Jan; 70(2):183-90.
        View in: PubMed PMC3152257
      33. Ikediobi ON, Shin J, Nussbaum RL, Phillips KA. Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther. 2009 Jul; 86(1):28-31.
        View in: PubMed PMC2910521
      34. Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J. A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics. 2009; 12(4):233-44.
        View in: PubMed PMC2844634
      35. Phillips KA. Closing the evidence gap in the use of emerging testing technologies in clinical practice. JAMA. 2008 Dec 3; 300(21):2542-4.
        View in: PubMed PMC2910511
      36. Phillips KA, Liang SY, Van Bebber S. Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value. Curr Opin Mol Ther. 2008 Jun; 10(3):260-6.
        View in: PubMed PMC2910510
      37. Lee JA, Afable-Munsuz A, Van Bebber SL, Phillips KA. Insured women and payment for elective abortion. Womens Health Issues. 2008 Sep-Oct; 18(5):347-50.
        View in: PubMed
      38. Haas JS, Fitzmaurice G, Brawarsky P, Liang SY, Hiatt RA, Klabunde CN, Brown ML, Phillips KA. Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis. 2007 Oct; 4(4):A90.
        View in: PubMed PMC2099288
      39. Issa AM, Phillips KA, Van Bebber S, Nidamarthy HG, Lasser KE, Haas JS, Alldredge BK, Wachter RM, Bates DW. Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007 Sep; 2(3):177-85.
        View in: PubMed
      40. Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health. 2007 Sep-Oct; 10(5):415-30.
        View in: PubMed
      41. Gellad WF, Huskamp HA, Phillips KA, Haas JS. Angiotensin receptor blockers on the formularies of Medicare drug plans. J Gen Intern Med. 2007 Aug; 22(8):1172-5.
        View in: PubMed PMC2305745
      42. Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL. Trends in colonoscopy for colorectal cancer screening. Med Care. 2007 Feb; 45(2):160-7.
        View in: PubMed
      43. Liang SY, Phillips KA, Haas JS. Measuring managed care and its environment using national surveys: a review and assessment. Med Care Res Rev. 2006 Dec; 63(6 Suppl):9S-36S.
        View in: PubMed
      44. Afable-Munsuz A, Gould H, Stewart F, Phillips KA, Van Bebber SL, Moore C. Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings. Contraception. 2007 Jan; 75(1):45-51.
        View in: PubMed
      45. Liang SY, Phillips KA, Nagamine M, Ladabaum U, Haas JS. Rates and predictors of colorectal cancer screening. Prev Chronic Dis. 2006 Oct; 3(4):A117.
        View in: PubMed PMC1779281
      46. Keenan PS, Neumann PJ, Phillips KA. Biotechnology and Medicare's new technology policy: lessons from three case studies. Health Aff (Millwood). 2006 Sep-Oct; 25(5):1260-9.
        View in: PubMed
      47. Phillips KA. The intersection of biotechnology and pharmacogenomics: health policy implications. Health Aff (Millwood). 2006 Sep-Oct; 25(5):1271-80.
        View in: PubMed
      48. Phillips KA, Van Bebber S, Marshall D, Walsh J, Thabane L. A review of studies examining stated preferences for cancer screening. Prev Chronic Dis. 2006 Jul; 3(3):A75.
        View in: PubMed PMC1636712
      49. Phillips KA, Van Bebber SL. Regulatory perspectives on pharmacogenomics: a review of the literature on key issues faced by the United States Food and Drug Administration. Med Care Res Rev. 2006 Jun; 63(3):301-26.
        View in: PubMed
      50. Phillips KA, Van Bebber S, Issa AM. Diagnostics and biomarker development: priming the pipeline. Nat Rev Drug Discov. 2006 Jun; 5(6):463-9.
        View in: PubMed
      51. Ladabaum U, Phillips KA. Colorectal cancer screening differential costs for younger versus older Americans. Am J Prev Med. 2006 May; 30(5):378-84.
        View in: PubMed
      52. Van Bebber SL, Phillips KA, Weitz TA, Gould H, Stewart F. Patient costs for medication abortion: results from a study of five clinical practices. Womens Health Issues. 2006 Jan-Feb; 16(1):4-13.
        View in: PubMed
      53. Gellad WF, Huskamp HA, Phillips KA, Haas JS. How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood). 2006 Jan-Feb; 25(1):248-55.
        View in: PubMed PMC1403812
      54. Phillips KA, Ackerman MJ, Sakowski J, Berul CI. Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases. Heart Rhythm. 2005 Dec; 2(12):1294-300.
        View in: PubMed
      55. Phillips KA, Liang SY, Haas JS, Stebbins M, Alldredge BK. Prescription drug dispensing limits and patterns. Manag Care Interface. 2005 Jul; 18(7):41-6.
        View in: PubMed
      56. Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med. 2005 Jun 7; 142(11):891-7.
        View in: PubMed
      57. Phillips KA, Van Bebber SL. Measuring the value of pharmacogenomics. Nat Rev Drug Discov. 2005 Jun; 4(6):500-9.
        View in: PubMed
      58. Gemperli MP, Stewart FH, Phillips KA, Sakowski J, Van Bebber S, Bergthold L. A qualitative study of insurers' coverage for mifepristone-induced abortion. Manag Care Interface. 2005 Mar; 18(3):26-30, 32.
        View in: PubMed
      59. Phillips KA, Van Bebber SL. A systematic review of cost-effectiveness analyses of pharmacogenomic interventions. Pharmacogenomics. 2004 Dec; 5(8):1139-49.
        View in: PubMed
      60. Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D. The effect of area HMO market share on cancer screening. Health Serv Res. 2004 Dec; 39(6 Pt 1):1751-72.
        View in: PubMed PMC1361096
      61. Haggstrom DA, Phillips KA, Liang SY, Haas JS, Tye S, Kerlikowske K. Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control. 2004 Nov; 15(9):883-92.
        View in: PubMed
      62. Phillips KA, Veenstra DL, Ramsey SD, Van Bebber SL, Sakowski J. Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs. Am J Manag Care. 2004 Jul; 10(7 Pt 1):425-32.
        View in: PubMed
      63. Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Baker LC, Kaplan CP, Pérez-Stable EJ, Liang SY. Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care. 2004 Jul; 42(7):707-14.
        View in: PubMed
      64. Sakowski JA, Phillips KA, Liang SY, Haas JS. Willingness to recommend a health plan: who is dissatisfied and what don't they like? Am J Manag Care. 2004 Jun; 10(6):393-400.
        View in: PubMed
      65. Phillips KA, Haas JS, Liang SY, Baker LC, Tye S, Kerlikowske K, Sakowski J, Spetz J. Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res. 2004 Feb; 39(1):153-78.
        View in: PubMed PMC1360999
      66. Liang SY, Phillips KA, Tye S, Haas JS, Sakowski J. Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care. 2004 Feb; 10(2 Pt 1):99-107.
        View in: PubMed
      67. Tye S, Phillips KA, Liang SY, Haas JS. Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res. 2004 Feb; 39(1):179-206.
        View in: PubMed PMC1361000
      68. Phillips KA, Stotland NE, Liang SY, Spetz J, Haas JS, Oren E. Out-of-pocket expenditures for oral contraceptives and number of packs per purchase. J Am Med Womens Assoc. 2004; 59(1):36-42.
        View in: PubMed
      69. Haas JS, Lee LB, Kaplan CP, Sonneborn D, Phillips KA, Liang SY. The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health. 2003 Dec; 93(12):2105-10.
        View in: PubMed PMC1448160
      70. Maddala T, Phillips KA, Reed Johnson F. An experiment on simplifying conjoint analysis designs for measuring preferences. Health Econ. 2003 Dec; 12(12):1035-47.
        View in: PubMed
      71. Phillips KA. Important step forward in HIV-testing technologies [correction of technolgies]. Am J Prev Med. 2003 Aug; 25(2):167.
        View in: PubMed
      72. Phillips KA, Veenstra D, Van Bebber S, Sakowski J. An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics. Pharmacogenomics. 2003 May; 4(3):231-9.
        View in: PubMed
      73. Haas JS, Phillips KA, Baker LC, Sonneborn D, McCulloch CE. Is the prevalence of gatekeeping in a community associated with individual trust in medical care? Med Care. 2003 May; 41(5):660-8.
        View in: PubMed
      74. Phillips KA, Chen JL. Willingness to use instant home HIV tests: data from the California Behavioral Risk Factor Surveillance Survey. Am J Prev Med. 2003 May; 24(4):340-8.
        View in: PubMed
      75. Phillips KA, Bayer R, Chen JL. New Centers for Disease Control and Prevention's guidelines on HIV counseling and testing for the general population and pregnant women. J Acquir Immune Defic Syndr. 2003 Feb 1; 32(2):182-91.
        View in: PubMed
      76. Phillips KA, Spetz J, Haas JS. Viagra and contraceptives. Health Aff (Millwood). 2003 Jan-Feb; 22(1):277.
        View in: PubMed
      77. Phillips KA, Johnson FR, Maddala T. Measuring what people value: a comparison of "attitude" and "preference" surveys. Health Serv Res. 2002 Dec; 37(6):1659-79.
        View in: PubMed PMC1464045
      78. Phillips KA, Maddala T, Johnson FR. Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing. Health Serv Res. 2002 Dec; 37(6):1681-705.
        View in: PubMed PMC1464051
      79. Haas JS, Phillips KA, Sonneborn D, McCulloch CE, Liang SY. Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care. 2002 Sep; 40(9):743-51.
        View in: PubMed
      80. Oren E, McCart G, Phillips KA. Evaluating the potential impact of pharmacogenomics on ADRs. J Manag Care Pharm. 2002 Jul-Aug; 8(4):285-90.
        View in: PubMed
      81. Phillips KA, Chen JL. Impact of the U.S. panel on cost-effectiveness in health and medicine. Am J Prev Med. 2002 Feb; 22(2):98-105.
        View in: PubMed
      82. Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001 Nov 14; 286(18):2270-9.
        View in: PubMed
      83. Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MG, Weinstein MC. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol. 2001 Oct; 38(4):1012-7.
        View in: PubMed
      84. Phillips KA. Current perspectives on BRCA1- and BRCA2-associated breast cancers. Intern Med J. 2001 Aug; 31(6):349-56.
        View in: PubMed
      85. Skolnik HS, Phillips KA, Binson D, Dilley JW. Deciding where and how to be tested for HIV: what matters most? J Acquir Immune Defic Syndr. 2001 Jul 1; 27(3):292-300.
        View in: PubMed
      86. Phillips KA, Shlipak MG, Coxson P, Heidenreich PA, Hunink MG, Goldman PA, Williams LW, Weinstein MC, Goldman L. Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA. 2000 Dec 6; 284(21):2748-54.
        View in: PubMed
      87. Phillips KA, Veenstra DL, Sadee W. Implications of the genetics revolution for health services research: pharmacogenomics and improvements in drug therapy. Health Serv Res. 2000 Dec; 35(5 Pt 3):128-40.
        View in: PubMed PMC1383600
      88. Phillips KA, Fernyak S. The cost-effectiveness of expanded HIV counselling and testing in primary care settings: a first look. AIDS. 2000 Sep 29; 14(14):2159-69.
        View in: PubMed
      89. Phillips KA, Mayer ML, Aday LA. Barriers to care among racial/ethnic groups under managed care. Health Aff (Millwood). 2000 Jul-Aug; 19(4):65-75.
        View in: PubMed
      90. Phillips KA, Morin S, Coates T, Fernyak S, Marsh A, Ramos-Irizarry L. Home sample collection for HIV testing. JAMA. 2000 Jan 12; 283(2):198-9.
        View in: PubMed
      91. Phillips KA, Fernyak S, Potosky AL, Schauffler HH, Egorin M. Use of preventive services by managed care enrollees: an updated perspective. Health Aff (Millwood). 2000 Jan-Feb; 19(1):102-16.
        View in: PubMed
      92. Veenstra DL, Higashi MK, Phillips KA. Assessing the cost-effectiveness of pharmacogenomics. AAPS PharmSci. 2000; 2(3):E29.
        View in: PubMed PMC2761139
      93. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA. 1999 Dec 8; 282(22):2156-63.
        View in: PubMed
      94. Phillips KA, Morrison KR, Andersen R, Aday LA. Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. Health Serv Res. 1998 Aug; 33(3 Pt 1):571-96.
        View in: PubMed PMC1070277
      95. Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women's adherence to mammography screening guidelines. Health Serv Res. 1998 Apr; 33(1):29-53.
        View in: PubMed PMC1070245
      96. Phillips KA, Homan RK, Hiatt PH, Luft HS, Kearney TE, Heard SE, Olson KR. The costs and outcomes of restricting public access to poison control centers. Results from a natural experiment. Med Care. 1998 Mar; 36(3):271-80.
        View in: PubMed
      97. Phillips KA, Luft HS. The policy implications of using hospital and physician volumes as "indicators" of quality of care in a changing health care environment. Int J Qual Health Care. 1997 Oct; 9(5):341-8.
        View in: PubMed
      98. Phillips KA, Homan RK, Luft HS, Hiatt PH, Olson KR, Kearney TE, Heard SE. Willingness to pay for poison control centers. J Health Econ. 1997 Jun; 16(3):343-57.
        View in: PubMed
      99. Phillips KA, Coates TJ, Catania JA. Predictors of follow-through on plans to be tested for HIV. Am J Prev Med. 1997 May-Jun; 13(3):193-8.
        View in: PubMed
      100. Phillips KA, Hotlgrave DR. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention? Am J Prev Med. 1997 Jan-Feb; 13(1):18-25.
        View in: PubMed
      101. Phillips KA, Bleecker T, Morrison KR, Sonnad SS. HIV counseling and testing of pregnant women. JAMA. 1996 Jul 24-31; 276(4):283-4.
        View in: PubMed
      102. Stall R, Hoff C, Coates TJ, Paul J, Phillips KA, Ekstrand M, Kegeles S, Catania J, Daigle D, Diaz R. Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1; 11(2):151-60.
        View in: PubMed
      103. Phillips KA, Bero LA. Improving the use of information in medical effectiveness research. Int J Qual Health Care. 1996 Feb; 8(1):21-30.
        View in: PubMed
      104. Phillips KA, Catania JA. Consistency in self-reports of HIV testing: longitudinal findings from the National AIDS Behavioral Surveys. Public Health Rep. 1995 Nov-Dec; 110(6):749-53.
        View in: PubMed PMC1381819
      105. Phillips KA, Paul J, Kegeles S, Stall R, Hoff C, Coates TJ. Predictors of repeat HIV testing among gay and bisexual men. AIDS. 1995 Jul; 9(7):769-75.
        View in: PubMed
      106. Phillips KA, Flatt SJ, Morrison KR, Coates TJ. Potential use of home HIV testing. N Engl J Med. 1995 May 11; 332(19):1308-10.
        View in: PubMed
      107. Phillips KA, Coates TJ, Eversley RB, Catania JA. Who plans to be tested for HIV or would get tested if no one could find out the results? Am J Prev Med. 1995 May-Jun; 11(3):156-62.
        View in: PubMed
      108. Phillips KA, Luft HS, Ritchie JL. The association of hospital volumes of percutaneous transluminal coronary angioplasty with adverse outcomes, length of stay, and charges in California. Med Care. 1995 May; 33(5):502-14.
        View in: PubMed
      109. Phillips KA, Coates TJ. HIV counselling and testing: research and policy issues. AIDS Care. 1995; 7(2):115-24.
        View in: PubMed
      110. De Zoysa I, Phillips KA, Kamenga MC, O'Reilly KR, Sweat MD, White RA, Grinstead OA, Coates TJ. Role of HIV counseling and testing in changing risk behavior in developing countries. AIDS. 1995; 9 Suppl A:S95-101.
        View in: PubMed
      111. Lurie P, Avins AL, Phillips KA, Kahn JG, Lowe RA, Ciccarone D. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA. 1994 Dec 21; 272(23):1832-8.
        View in: PubMed
      112. Phillips KA. The relationship of 1988 state HIV testing policies to previous and planned voluntary use of HIV testing. J Acquir Immune Defic Syndr. 1994 Apr; 7(4):403-9.
        View in: PubMed
      113. Phillips KA, Lowe RA, Kahn JG, Lurie P, Avins AL, Ciccarone D. The cost-effectiveness of HIV testing of physicians and dentists in the United States. JAMA. 1994 Mar 16; 271(11):851-8.
        View in: PubMed
      114. Ritchie JL, Phillips KA, Luft HS. Coronary angioplasty. Statewide experience in California. Circulation. 1993 Dec; 88(6):2735-43.
        View in: PubMed
      115. Phillips KA. Subjective knowledge of AIDS and use of HIV testing. Am J Public Health. 1993 Oct; 83(10):1460-2.
        View in: PubMed PMC1694859
      116. Phillips KA. Factors associated with voluntary HIV testing for African-Americans and Hispanics. AIDS Educ Prev. 1993; 5(2):95-103.
        View in: PubMed
      117. Phillips KA, Rosenblatt A. Speaking in tongues: integrating economics and psychology into health and mental health services outcomes research. Med Care Rev. 1992; 49(2):191-231.
        View in: PubMed
      118. Paringer L, Phillips KA, Hu TW. Who seeks HIV testing? The impact of risk, knowledge, and state regulatory policy on the testing decision. Inquiry. 1991; 28(3):226-35.
        View in: PubMed
      Kathryn's Networks
      Related Concepts
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Related Authors
      People who share related concepts with this person.
      Back to TOP